These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 12575965

  • 1. The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration.
    Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF.
    J Am Coll Cardiol; 2003 Feb 05; 41(3):394-402. PubMed ID: 12575965
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
    Marmur JD, Lakhani M, El Rouby S, Cavusoglu E.
    J Invasive Cardiol; 2008 Sep 05; 20(9):449-54. PubMed ID: 18762674
    [Abstract] [Full Text] [Related]

  • 4. Activated clotting time (ACT)-guided intravenous dalteparin dosing during percutaneous coronary intervention.
    Marmur JD, Poludasu S, Feit A, Battala VR, Cavusoglu E.
    J Invasive Cardiol; 2008 Jul 05; 20(7):323-7. PubMed ID: 18599887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Characteristics in Healthy Adults and Critically Ill Patients.
    Wehner JE, Boehne M, David S, Brand K, Tiede A, Bikker R.
    Clin Appl Thromb Hemost; 2020 Jul 05; 26():1076029620975494. PubMed ID: 33350327
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.
    Dieplinger B, Egger M, Luft C, Hinterreiter F, Pernerstorfer T, Haltmayer M, Mueller T.
    J Vasc Surg; 2018 Aug 05; 68(2):400-407. PubMed ID: 29571622
    [Abstract] [Full Text] [Related]

  • 11. High-dose intravenous dalteparin can be monitored effectively using standard coagulation times.
    Wilson JM, Gilbert J, Harlan M, Bracey A, Allison P, Schooley C, Pinto K.
    Clin Appl Thromb Hemost; 2005 Apr 05; 11(2):127-38. PubMed ID: 15821819
    [Abstract] [Full Text] [Related]

  • 12. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins.
    Bendz B, Hansen JB, Andersen TO, Ostergaard P, Sandset PM.
    Br J Haematol; 1999 Dec 05; 107(4):756-62. PubMed ID: 10606880
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.